Hydroxychloroquine in Type 2 Diabetes During Pregnancy
Eligible age
20–45 yrs
Accepts
Women
Locations
0 states
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The goal of this clinical trial is to compare the use of hydroxychloroquine as an adjunct to the current treatment of pregnant women with Type 2 diabetes mellitus. The main questions it aims to answer are: * Does hydroxychloroquine improve the pregnancy outcomes in women with type 2 diabetes during pregnancy? * Does hydroxychloroquine improve the inflammatory markers in women with type 2 diabetes during pregnancy? Participants will be randomised into the intervention and control group. The control group will be on standard treatment where as the intervention group will receive hydroxychloroquine as an adjunct of standard treatment
Sponsor: National University of Malaysia
You may qualify if…
- ✓ Singleton
- ✓ Pregnant women with a confirmed diagnosis of type 2 Diabetes Mellitus
You may not qualify if…
- ✕ autoimmune disease such as Systemic Lupus Erythematosus or rheumatic disease
- ✕ chronic kidney disease
- ✕ fetal anomaly
- ✕ women on steroid therapy
- ✕ diabetic retinopathy
- ✕ known thalassaemia or thalassaemia carrier
Source: ClinicalTrials.gov · NCT06319560 · last updated 2025-06-12